Zurcher Kantonalbank (Zurich Cantonalbank) Dyne Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 19,247 shares of DYN stock, worth $268,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,247
Previous 19,247
-0.0%
Holding current value
$268,495
Previous $201,000
8.96%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$136 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$132 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$127 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$107 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$103 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $722M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...